Opinions
Bruce Campbell (2)
Nurosene Health
MEND-CSE
BUY
Jan 19, 2023
AI technology that lets drug companies screen out participants for trials. Pinpoints who they should include and who they shouldn't, leading to more success of trials. Doing an excellent job. Waiting for a bigger contract from a bigger company. Hasn't performed that well, but worst is behind them.
N/A
Stock price when the opinion was issued
Healthcare
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
WATCH
They just IPO'd that he participated in. It's on the CSE, so he didn't make it a top pick today. Brain health is moving to the forefront. They combine tech and natural ingredients to promote brain health, like apps to keep the mind sharp. Michael Phelps is on the board among other notables. He's watching it. The company has room to grow.
Healthcare
PAST TOP PICK
(A Top Pick Nov 19/21, Down 88%) A.I. technology for pharmaceutical industry. Allows for further identification of illness within patients. Technology building to the point of being commercial. Looking to the future for a robust sales pipeline. No profits yet. Will continue to hold shares.
Healthcare